Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.

Cited by (629)

Items 301–400 of 629

1. Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease
   Hasan A. M. M. Almansoub, Hui Ru Tang, Ying Wu, Ding‐Qi Wang, Yacoubou Abdoul Razak Mahaman, Na Wei, Yusra A. M. Almansob, Wei He, Dan Liu · 2018 · Journal of Alzheimer s Disease
2. Medial septum tau accumulation induces spatial memory deficit via disrupting medial septum–hippocampus cholinergic pathway
   Dongqin Wu, Di Gao, Hai-Tao Yu, Gui-Lin Pi, Rui Xiong, Huiyang Lei, Xin Wang, En-Jie Liu, Jin-Wang Ye, Hui-Ling Yu et al. · 2021 · Clinical and Translational Medicine
3. Neuroprotective Effects and Mechanisms of Senegenin, an Effective Compound Originated From the Roots of Polygala Tenuifolia
   Zhe Chen, Yang Yu, Ying Han, Xijun Wang · 2022 · Frontiers in Pharmacology
4. Role of the ubiquitin–proteasome pathway in the diagnosis of human diseases
   Jakub Gołąb, Thomas M. Bauer, Volker Daniel, Cord Naujokat · 2003 · Clinica Chimica Acta
5. Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons
   Osamu Yasuhara, Akinori Matsuo, Ikuo Tooyama, Hiroshi Kimurâ, Edith G. McGeer, Patrick L. McGeer · 1995 · Acta Neuropathologica
6. Ubiquitin and heat shock protein expression in amyotrophic lateral sclerosis
   O. Garofalo, Peter G. E. Kennedy, Michael Swash, Joanne E. Martin, Philip J. Luthert, Brian H. Anderton, P. Nigel Leigh · 1991 · Neuropathology and Applied Neurobiology
7. Proteasome or calpain inhibition does not alter cellular tau levels in neuroblastoma cells or primary neurons
   Maile R. Brown, Vimala Bondada, Jeffrey N. Keller, Jeffery A. Thorpe, James W. Geddes · 2005 · Journal of Alzheimer s Disease
8. Evidence for a particulate location of ubiquitin conjugates and ubiquitin-conjugating enzymes in rabbit brain.
   Mauro Magnani, Giordano Serafini, A. Antonelli, Manuela Malatesta, Giancarlo Gazzanelli · 1991 · Journal of Biological Chemistry
9. Immunoreactivity to ubiquitin—protein conjugates is present early in the disease process in the brains of scrapie‐infected mice
   James S Lowe, Jill Fergusson, Nigel Kenward, Lajos László, Michael Landon, Christine F. Farquhar, John Brown, James Hope, R. John Mayer · 1992 · The Journal of Pathology
10. Neuronal degeneration in human diseases and animal models
    Donald L. Price, Lee J. Martin, Richard E. Clatterbuck, Vassilis E. Koliatsos, Sangram S. Sisodia, Lary C. Walker, Linda C. Cork · 1992 · Journal of Neurobiology
11. Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model
    José Morales‐Corraliza, Stephen D. Schmidt, Matthew J. Mazzella, Jason D. Berger, Donald A. Wilson, Daniel W. Wesson, Mathias Jucker, Efrat Levy, Ralph A. Nixon, Paul M. Mathews · 2012 · Neurobiology of Aging
12. Ubiquitin is Associated with Early Truncation of Tau Protein at Aspartic Acid421 during the Maturation of Neurofibrillary Tangles in Alzheimer's Disease
    Francisco García‐Sierra, José Jaime Jarero-Basulto, Zdena Krištofíková, Emerich Majer, Lester I. Binder, Daniela Řı́pová · 2011 · Brain Pathology
13. Immunohistochemical study of constituents other than β-protein in canine senile plaques and cerebral amyloid angiopathy
    Kazuyuki Uchida, Koji Kuroki, Tomoko Yoshino, Ryoji Yamaguchi, Susumu TATEYAMA · 1997 · Acta Neuropathologica
14. The neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype
    Paula van Tijn, Elly M. Hol, Fred W. van Leeuwen, David F. Fischer · 2008 · Progress in Neurobiology
15. The Amyloid Peptide and Its Precursor in Alzheimer's Disease
    Jean Noël Octave · 1995 · Reviews in the Neurosciences
16. Diagnosis of Alzheimer's Disease
    ‌Barry Reisberg, Alistair S. Burns, Henry Brodaty, Robin Eastwood, Martin N. Rossor, Norman Sartorius, Bengt G. Winblad · 1997 · International Psychogeriatrics
17. Ubiquitin and the Molecular Pathology of Neurodegenerative Diseases
    James S Lowe, John Mayer, Michael Landon, Robert Layfield · 2001 · Advances in experimental medicine and biology
18. Synphilin-1 isoforms in Parkinson’s disease: regulation by phosphorylation and ubiquitylation
    Raymonde Szargel, R. Rott, Simone Engelender · 2007 · Cellular and Molecular Life Sciences
19. Biomarkers for Alzheimer Disease in Cerebrospinal Fluid, Urine, and Blood
    Anders Lönneborg · 2008 · Molecular Diagnosis & Therapy
20. Two distinct ubiquitin immunoreactive senile plaques in Alzheimer's disease: relationship with the intellectual status in 29 cases
    Y. He, Pia Delaère, Charles J. Duyckaerts, Marcin Wąsowicz, F. Piette, Jean‐Jacques Hauw · 1993 · Acta Neuropathologica
21. Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives
    Ritesh P. Bhole, Rupesh V. Chikhale, Karishma Manohar Rathi · 2023 · IBRO Neuroscience Reports
22. Alzheimer disease: An imbalance of proteolytic regulation?
    Mark A. Smith, George L. Perry · 1994 · Medical Hypotheses
23. Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production
    Qing‐Shan Xue, D. Larry Sparks, Wolfgang J. Streit · 2007 · Journal of Neuroinflammation
24. Abortive oncogeny and cell cycle-mediated events in Alzheimer disease
    Arun K. Raina, Xiongwei Zhu, Mervyn J. Monteiro, Atsushi Takeda, Mark A. Smith · 2000 · Springer eBooks
25. Alzheimer neurofibrillary tangles contain 2.1 nm filaments structurally identical to the microtubule-associated protein τ: a high-resolution transmission electron microscope study of tangles and senile plaque core amyloid
    George C. Ruben, Khalid Iqbal, Henryk M. Wisniewski, John Emil Johnson, Inge Grundke · 1992 · Brain Research
26. Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and β-amyloid
    Kedar Nath Prasad, Francisco G. La Rosa, Judith E. Prasad · 1998 · In Vitro Cellular & Developmental Biology - Animal
27. The heat shock/oxidative stress connection
    Miguel A. Pappolla, M. Sos, R. A. Omar, Kumar Sambamurti · 1996 · Molecular and Chemical Neuropathology
28. Chapter 3 Ubiquitin and its role in neurodegeneration
    Jane Arnold, Simon P. Dawson, Jill Fergusson, Michael Landon, R. John Mayer, James S Lowe · 1998 · Progress in brain research
29. Along the way to a neurofibrillary tangle: a look at the structure of tau
    Kosik, Kenneth S., Kowall, Neil W., McKee, Ann · 1989 · Annals of Medicine
30. Phosphorylation of Tau Protein Associated as a Protective Mechanism in the Presence of Toxic, C-Terminally Truncated Tau in Alzheimer's Disease
    José Luna‐Muñoz, R. Charles, Claude M., Paola Flores-Rodríguez, Jesús Ávila, Rubin Sergio, Fidel de la Cruz, Raúl Mena, Marco Antonio Meraz‐Ríos, Benjamín Florán · 2013 · InTech eBooks
31. TMP21 degradation is mediated by the ubiquitin‐proteasome pathway
    Shengchun Liu, Kelley Bromley‐Brits, Kun Xia, Jill Mittelholtz, Ruitao Wang, Weihong Song · 2008 · European Journal of Neuroscience
32. A specific inhibitor of the ubiquitin activating enzyme: synthesis and characterization of adenosyl-phospho-ubiquitinol, a nonhydrolyzable ubiquitin adenylate analog
    Keith D. Wilkinson, Stephen E. Smith, Lydia B. O'Connor, E J Sternberg, John J. Taggart, David A. Berges, Tauseef R. Butt · 1990 · Biochemistry
33. The Occurrence of Aging-Dependent Reticulon 3 Immunoreactive Dystrophic Neurites Decreases Cognitive Function
    Qi Shi, Xiangyou Hu, Marguerite Prior, Riqiang Yan · 2009 · Journal of Neuroscience
34. Protein gene product 9.5 and ubiquitin immunoreactivities in rat epididymis epithelium
    Luis Santamaráa, Rosario Mart�n, Ricardo Paniagua, Benito Fraile, Manuel Nistal, G. Terenghi, Julia Margaret Polak · 1993 · Histochemistry and Cell Biology
35. Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology
    Subha Kalyaanamoorthy, Stanley K. A. Opare, Xiaoxiao Xu, Aravindhan Ganesan, Praveen P. N. Rao · 2024 · Current Alzheimer Research
36. Proteasome subunit proteins and neuropathology in tauopathies and synucleinopathies: Consequences for proteomic analyses
    Mohamed Zouambia, David F. Fischer, Barbara Hobo, Rob A. I. de Vos, Elly M. Hol, Ian M. Varndell, Paul W. Sheppard, Fred W. van Leeuwen · 2008 · PROTEOMICS
37. Ubiquitin and β-amyloid-protein in inclusion body myositis (IBM), familial IBM-like disorder and oculopharyngeal muscular dystrophy: An immunocytochemical study
    Anne Helbling-Leclerc, Fernando M. S. Tomé, Michel Fardeau · 1993 · Neuromuscular Disorders
38. Non-covalent interaction of ubiquitin with insulin-degrading enzyme
    Tomo Šarić, Dieter Müller, Hans-Joachim Seitz, Krešimir Pavelić · 2003 · Molecular and Cellular Endocrinology
39. Exploring the anti-ferroptosis mechanism of Kai-Xin-San against Alzheimer's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vivo and in vitro
    Chenchen Yan, Song Yang, Simai Shao, Runru Zu, Lu Hao, Yuanzhao Chen, Yangang Zhou, Xiran Ying, Shixie Xiang, Peixu Zhang et al. · 2024 · Journal of Ethnopharmacology
40. Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases
    Md. Tanvir Kabir, Md. Sahab Uddin, Ahmed Abdeen, Ghulam Md Ashraf, Asma Perveen, Abdul Hafeez, May Nasser Bin-Jumah, Mohamed M. Abdel‐Daim · 2020 · Current Topics in Medicinal Chemistry
41. Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver
    Takuya Osada, Michiie Sakamoto, Hideki Nishibori, Keiichi Iwaya, Yoshihiro Matsuno, Tetsuichiro Muto, Setsuo Hirohashi · 1997 · Journal of Hepatology
42. Immunoaffinity demonstration that paired helical filaments of Alzheimer disease share epitopes with neurofilaments, MAP2 and tau
    Paul Mulvihill, George L. Perry · 1989 · Brain Research
43. The Ubiquitin Proteasome System as a Potential Target for the Treatment of Neurodegenerative Diseases
    Zheng Ying, Hongfeng Wang, Guanghui Wang · 2013 · Current Pharmaceutical Design
44. Methods for the purification of ubiquitinated Proteins
    Emma Tomlinson, Naaventhan Palaniyappan, David Tooth, Robert Layfield · 2007 · PROTEOMICS
45. Primary central white matter degeneration in old dogs
    Isidró Ferrer, Martí Batlle Pumarola, R. Rivera, M.J. Z�jar, F. F. Cruz-S�nchez, August Vidal · 1993 · Acta Neuropathologica
46. Ubiquitin immunoreactivity in human malignant tumours
    Yoshio Ishibashi, Koji Takada, Kensuke Joh, Kiyoshi Ohkawa, Tomokazu Aoki, M Matsuda · 1991 · British Journal of Cancer
47. Complementation by a Cloned Human Ubiquitin-Activating Enzyme E1 of the S-Phase-Arrested Mouse FM3A Cell Mutant with Thermolabile E1.
    Dai Ayusawa, Sumiko Kaneda, Yoshiyasu Itoh, Hideyo Yasuda, Yasuko Murakami, Kaoru Sugasawa, Fumio Hanaoka, Takeshi Seno · 1992 · Cell Structure and Function
48. Relationships between stress protein induction and NMDA-mediated neuronal death in the entorhinal cortex
    Wendy M. Yee, David M. Frim, Ole Isacson A · 1993 · Experimental Brain Research
49. The influence of APOEε4 on the pTau interactome in sporadic Alzheimer’s disease
    Manon Thierry, Jackeline Ponce, Mitchell Martá-Ariza, Manor Askenazi, Arline Faustin, Dominique Leitner, Geoffrey Pires, Evgeny Kanshin, Eleanor Drummond, Beatrix M. Ueberheide et al. · 2024 · Acta Neuropathologica
50. Alzheimer's Disease and the “Valley of Death”: Not Enough Guidance from Human Brain Tissue?
    Thomas G. Beach · 2012 · Journal of Alzheimer s Disease
51. Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
    Simon Sjödin, Oskar Hansson, Annika Öhrfelt, Gunnar Brinkmalm, Henrik Zetterberg, Ann Brinkmalm, Kaj Blennow · 2017 · PROTEOMICS - CLINICAL APPLICATIONS
52. Immunocytochemical localization of ubiquitin at human neuromuscular junctions
    P. SERDAROGLU, Valerie Askanas, W. King Engel · 1992 · Neuropathology and Applied Neurobiology
53. Localization of immunoreactive ubiquitin in the nervous system of the Manduca sexta moth
    Susan E. Fahrbach, L. M. Schwartz · 1994 · The Journal of Comparative Neurology
54. Characterization of tau protein present in microtubules and paired helical filaments of Alzheimer's disease patient's brain
    Antonio Nieto, Esteban Montejo de Garcini, Isabel Correas, Jesús Ávila · 1990 · Neuroscience
55. Distinct effects of ubiquitin overexpression on NMJ structure and motor performance in mice expressing catalytically inactive USP14
    Jada H. Vaden, Jennifer A. Watson, Alan D. Howard, Ping‐Chung Chen, Julie A. Wilson, Scott M. Wilson · 2015 · Frontiers in Molecular Neuroscience
56. Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity
    Arun Upadhyay, Deepak Chhangani, Nalini R. Rao, Julia Kofler, Robert J. Vassar, Diego E. Rincón-Limas, Jeffrey N. Savas · 2023 · Molecular Neurodegeneration
57. Opioid system functional regulation in neurological disease management
    Mohan Sobhana Nandhu, Naijil George, Smijin K. Soman, S. Jayanarayanan, C.S. Paulose · 2010 · Journal of Neuroscience Research
58. Alzheimer's lesions labelled by anti‐ubiquitin antibodies: comparison with other staining techniques. A study of 15 cases with graded intellectual status in ageing and Alzheimer's disease
    Y. He, Charles J. Duyckaerts, Pia Delaère, F. Piette, J J Hauw · 1993 · Neuropathology and Applied Neurobiology
59. Proteasome inhibition induces stress kinase dependent transport deficits — Implications for Alzheimer's disease
    Lotta Agholme, Sangeeta Nath, Jakob Domert, Jan O. Marcusson, Katarina Kågedal, Martin Hallbeck · 2013 · Molecular and Cellular Neuroscience
60. Molecular chaperones and age-related degenerative disorders
    Alberto J.L. Macario, Everly Conway de Macario · 2001 · Advances in cell aging and gerontology
61. Cerebrospinal fluid profile of amyloid β42 (Aβ42), hTau and ubiquitin in North Indian Alzheimer's disease patients
    Ramesh J. L. Kandimalla, S Prabhakar, Balachandran Krishnamma Binukumar, Willayat Yousuf Wani, Deep Raj Sharma, V. Grover, Neerja Bhardwaj, Kajal Jain, Kiran Dip Gill · 2010 · Neuroscience Letters
62. Exploring the selective vulnerability in Alzheimer disease using tissue specific variant analysis
    S. Akila Parvathy Dharshini, Y‐h. Taguchi, M. Michael Gromiha · 2018 · Genomics
63. Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry
    Andrea Renee Kelley, Stephan B. H. Bach, George L. Perry · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
64. Dystrophic neurites around amyloid plaques of human patients with Gerstmann-Sträussler-Scheinker disease contain ubiquitinated inclusions
    Antonio Migheli, Angelo Attanasio, Maria Claudia Vigliani, D. Schiffer · 1991 · Neuroscience Letters
65. Cellular and molecular biology of alzheimer's disease
    Donald L. Price, Edward H. Koo, Axel Unterbeck · 1989 · BioEssays
66. Antibodies to fibronectin bind to plaques and other structures in Alzheimer's disease and control brain
    Jonathan Howard, Geoffrey John Pilkington · 1990 · Neuroscience Letters
67. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease
    Ilie‐Cosmin Stancu, Mattia Ferraiolo, Dick Terwel, Ilse Dewachter · 2019 · Advances in experimental medicine and biology
68. Identification of linear polyubiquitin chain immunoreactivity in tau pathology of Alzheimer’s disease
    Yoshiaki Nakayama, Shinji Sakamoto, Kazumi Tsuji, Takashi Ayaki, Fuminori Tokunaga, Hidefumi Ito · 2019 · Neuroscience Letters
69. Expression of ubiquitin-like immunoreactivity in axons after compression trauma to rat spinal cord
    G. L. Li, M. Farooque · 1996 · Acta Neuropathologica
70. Pyrazolones Activate the Proteasome by Gating Mechanisms and Protect Neuronal Cells from β‐Amyloid Toxicity
    Anna Maria Santoro, Valeria Lanza, Francesco Bellia, Diego Sbardella, Grazia Raffaella Tundo, Alessandra Cannizzo, Giuseppe Grasso, Mariaconcetta Arizzi, Vincenzo Giuseppe Nicoletti, Stefano Alcaro et al. · 2019 · ChemMedChem
71. Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice
    Yuxing Xia, Stefan Prokop, Brach M. Bell, Kimberly-Marie M. Gorion, Cara L. Croft, Lith H. Nasif, Guilian M. Xu, Cara J. Riffe, Alyssa N. Manaois, Kevin H. Strang et al. · 2022 · Communications Biology
72. The treatment of Alzheimer's disease
    N. H. P. Allen, Alistair S. Burns · 1995 · Journal of Psychopharmacology
73. Ubiquitin and ubiquitin-protein conjugates in PC12h cells: Changes during neuronal differentiation
    Koji Takada, Tosaku Kanda, Kiyoshi Ohkawa, Makoto Matsuda · 1994 · Neurochemical Research
74. A method to identify p62’s UBA domain interacting proteins
    Julia W. Pridgeon, Thangiah Geetha, Marie W. Wooten · 2003 · Biological Procedures Online
75. Role of tau in the polymerization of peptides from β-amyloid precursor protein
    Claudia B. Caputo, Linda A. Sygowski, Clay W. Scott, Irene R. Evangelista Sobel · 1992 · Brain Research
76. The Neuropathology of Alzheimer’s Disease
    Peter L Lantos, Nigel J. Cairns · 1994 · Springer eBooks
77. Immortalized Alzheimer’s Disease Astrocytes: Characterization of Their Proteolytic Systems
    Chunmei Gong, Laura Bonfili, Yadong Zheng, Valentina Cecarini, Massimiliano Cuccioloni, Mauro Angeletti, Giulia Dematteis, Laura Tapella, Armando A. Genazzani, Dmitry Lim et al. · 2023 · Molecular Neurobiology
78. Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus
    Randall L. Woltjer, Lindsay C. Reese, Brian E. Richardson, Huong Thi Diem Tran, Sarah Green, Thao Pham, Megan Chalupsky, Isabella Gabriel, Tyler J. Light, Lynn Sanford et al. · 2015 · Molecular Genetics and Metabolism
79. UPS Activation in the Battle Against Aging and Aggregation-Related Diseases: An Extended Review
    Nikoletta Papaevgeniou, Niki Chondrogianni · 2016 · Methods in molecular biology
80. 20S proteasome and glyoxalase 1 activities decrease in erythrocytes derived from Alzheimer’s disease patients
    Chongdong Jian, Hui Lv, Guiyuan Wei, Can-Shou Guo, Yu-Feng Deng, Yongming Jiang, Ce Gao · 2019 · Neural Regeneration Research
81. Ubiquitin and the molecular pathology of chronic degenerative diseases
    R. John Mayer, James S Lowe, Michael Landon · 1991 · The Journal of Pathology
82. Second Messengers in Neuronal Growth and Degeneration
    Mark P. Mattson · 1990
83. Altered Proteostasis in Neurodegenerative Tauopathies
    Katerina Papanikolopoulou, Efthimios M. C. Skoulakis · 2020 · Advances in experimental medicine and biology
84. Stimulation of the Amyloidogenic Pathway by Cytoplasmic Superoxide Radicals in an Alzheimer's Disease Mouse Model
    Kazuma Murakami, Nakaba Murata, Yoshihiro Noda, Kazuhiro Irie, Takuji Shirasawa, Takahiko Shimizu · 2012 · Bioscience Biotechnology and Biochemistry
85. Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease
    Madeleine Zetterberg, Annica Sjölander, Malin von Otter, Mona Seibt Palmér, Sara Landgren, Lennart Minthon, Anders Wallin, Niels Andreasen, Kaj Blennow, Henrik Zetterberg · 2010 · Molecular Neurodegeneration
86. Amyloid precursor protein, Aβ and amyloid-associated proteins involved in chloroquine retinopathy in rats – immunopathological studies
    Taku Yoshida, Ryo Fukatsu, Kayo Tsuzuki, Yuji Aizawa, Yorihide Hayashi, Nobuyuki Sasaki, Yuji Takamaru, Nobuhiro Fujii, Naohiko Takahata · 1997 · Brain Research
87. The mechanisms of Mallory–Denk body formation are similar to the formation of aggresomes in Alzheimer's disease and other neurodegenerative disorders
    Samuel William French, Alejandro S. Mendoza, Yue Peng · 2016 · Experimental and Molecular Pathology
88. Trophic modulation of gamma oscillations: The key role of processing protease for Neuregulin-1 and BDNF precursors
    Hideki Tamura, Sadao Shiosaka, Shota Morikawa · 2017 · Neurochemistry International
89. Induction of NADPH cytochrome P450 reductase by the Alzheimer β‐protein. Amyloid as a ‘foreign body’
    Miguel A. Pappolla, Rawhi Omar, Yau‐Jan Chyan, Jorge A. Ghiso, Karen Hsiao, Peter Bozner, George L. Perry, Mark A. Smith, Felix Cruz-Sánchez · 2001 · Journal of Neurochemistry
90. Heterogeneity of ubiquitin immunoreactivity in neurofibrillary tangles of Alzheimer's disease
    Jean‐Pierre Brion, Deborah Mary Power, D. Hue, A. M. Couck, Brian H. Anderton, J Flament-Durand · 1989 · Neurochemistry International
91. Protease Inhibition Causes Some Manifestations of Aging and Alzheimer's Disease in Rodent and Primate Braina
    Gwen O. Ivy · 1992 · Annals of the New York Academy of Sciences
92. Immunohistochemical Study of the Hippocampus in Parkinsonism-Dementia Complex on Guam
    Hidefumi Ito, Satoshi Goto, Asao Hirano, Shu-Hui C. Yen · 1991 · Journal of Geriatric Psychiatry and Neurology
93. The Ubiquitin System in Higher and Lower Plants — Pathways in Protein Metabolism
    Lutz Pollmann, Michael Wettern · 1989 · Botanica Acta
94. Immunohistochemical study of microtubule-associated protein 2 and ubiquitin in chronically aluminum-intoxicated rabbit brain
    Masahiro Takeda, Yoshitaka Tatebayashi, Satoshi Tanimukai, Yoshihiro NAKAMURA, Toshihisa Tanaka, Takashi Nishimura · 1991 · Acta Neuropathologica
95. Linear Polyubiquitin Chain Modification of TDP-43-Positive Neuronal Cytoplasmic Inclusions in Amyotrophic Lateral Sclerosis
    Nakayama, Yoshiaki, Tsuji, Kazumi, Ayaki, Takashi, Mori, Megumi, Tokunaga, Fuminori, Ito, Hidefumi · 2020 · Journal of Neuropathology & Experimental Neurology
96. SUMO modulation of protein aggregation and degradation
    Marco Feligioni, Serena Marcelli, Erin Knock, Urooba Nadeem, Ottavio Arancio, Paul E. Fraser · 2015 · AIMS molecular science
97. The national DBS brain tissue network pilot study: need for more tissue and more standardization
    Vinata Vedam‐Mai, Nolie E. Krock, M. Ullman, Kelly D. Foote, William G. Shain, K. Smith, Anthony T. Yachnis, Dennis A. Steindler, Brent A. Reynolds, S. Merritt et al. · 2010 · Cell and Tissue Banking
98. Pentosidine Accumulation in Human Oocytes and Their Correlation to Age-Related Apoptosis
    Miki Matsumine, Noriyuki Shibata, Ken Ishitani, Makio Kobayashi, Hiroaki Ohta · 2008 · ACTA HISTOCHEMICA ET CYTOCHEMICA
99. Deficiency of fibrinolytic enzyme activities in the serum of patients with Alzheimer-type dementia
    Takao Aoyagi, Takao Wada, F. Kojima, MACHIKO NAGAI, Shūzi Harada, Tsutomu Takeuchi, Kunihiro Isse, M. Ogura, Makoto Hamamoto, Keizo TANAKA et al. · 1992 · Cellular and Molecular Life Sciences
100. Potential roles of protease inhibitors in Alzheimer's disease
     Carmela R. Abraham · 1989 · Neurobiology of Aging